Based on the China Drug Administration Regulations, the Good Manufacturing Practice (GMP) and Good Supply Practice (GSP) list the mandatory requirements and basic guidelines covering pharmaceutical products manufacturing and quality control to ensure the safety and quality of these products and reduce the risks in their distribution. In this aspect, GMP certification can help improve the overall level of pharmaceutical production management, while GSP can enhance the pharmaceutical trading situation and its supply chain system.
The new versions of GMP2010 / GSP2013 have been released and implemented for some time and enterprises engaged in this sector must be aware of these new requirements. Enterprises that do not meet the requirements of the new guidelines would risk not being able to continue their production. Upgrading their production standard is necessary to receive these certifications.
Testo product application engineer, Mr. Guo Weimin, will talk in detail about the GMP and GSP regulations, and how to meet the new guidelines. He will also talk about other important aspects of production such as the use of portable measuring instruments, testo wireless temperature and humidity monitoring systems for data monitoring, data archiving, alarm management, data traceability, electronic signatures, etc.
On September 22, 2015 from 14:00 - 15:00, we look forward to your participation! For more information or to register, click here.(The webinar is in Chinese.)
1. Introduction on GMP and GSP regulations
2. Measuring equipment part solutions
3. Authentication service part solutions
4. Calibration device part solutions
Tue, Sep 22nd 2015, 14:00
- to -
Tue, Sep 22nd 2015, 15:00 (GMT +08:00)
Testo AG, with its headquarters in Lenzkirch in the Black Forest, is a world market leader in the field of portable and stationary measurement technology. Worldwide, 2,450 staff are involved in research, production and marketing for the high-tech company, working to find innovative measurement solutions, e.g. in the fields of air conditioning and ventilation, food quality, building technology and emission control.
In 2012, Testo AG achieved a turnover of 221 million Euros. The basis for this success was, in addition to the highly qualified and motivated staff, the above-average investment in a future-oriented development. Roughly 10 percent of the concern's annual worldwide turnover is spent on Research & Development – a sustainable and success-oriented step towards the future.
|View other Testo AG events